A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/437 (2006.01) A61K 31/515 (2006.01) A61K 31/5513 (2006.01) A61K 31/5517 (2006.01) A61K 31/565 (2006.01) A61K 31/5685 (2006.01) A61P 27/02 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2439842
The invention relates to the use of pharmaceutical compositions comprising GABA-receptor modulators in ophthalmology, for the prevention and/or treatment of neurodegenerative diseases of the eye, whereby the GABA-receptor modulators are selected from the group comprising benzodiazepines, benzodiazepine- receptor ligands of various structures, beta-carbolines, barbiturates, barbituric acid derivatives and/or neurosteroids.
L'invention concerne l'utilisation de compositions pharmaceutiques contenant un modulateur du récepteur GABA en ophtalmologie pour la prévention, le prétraitement et/ou le post-traitement de maladies neurodégénératives de l'oeil, les modulateurs du récepteur GABA étant sélectionnés dans le groupe comprenant les benzodiazépines, les ligands au récepteur de benzodiazépine de différentes structures, les bêta-carbolines, les barbiturates, les dérivés d'acide barbiturique et/ou les neurostéroïdes.
Allmeier Helmut
Bruckner Christopher
Kessler Christoph
Reimer-Hevia Cornelia
Borden Ladner Gervais Llp
Dr. Gerhard Mann Chem.-Pharm.fabrik Gmbh
LandOfFree
Gaba-receptor modulators for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gaba-receptor modulators for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gaba-receptor modulators for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1946722